Our results revealed machine learning with novel biomarkers and multiple variables may increase the sensitivity and specificity in diagnosis of AD. Rapid and cost-effective HPLC for biomarkers and machine learning algorithms may assist physicians in diagnosing AD in outpatient clinics.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2021) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: